Newsfeeds Archive - Page 436 of 461

1 minute read

Deciphera’s Cancer Drug Tops Pfizer’s Sutent On Safety Front In Gastrointestinal Cancer

August 11, 9:45 AM

The Journal of Clinical Oncology has published results from Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) INTRIGUE Phase 3 study of Qinlock (ripretinib) for advanced…

DCPH

1 minute read

Cardinal Health Names New Chief Executive, Posts Mixed Q4 Earnings

By Vandana Singh

August 11, 8:26 AM

Cardinal Health Inc (NYSE:CAH) has reported Q4 FY22 adjusted EPS of $1.05, up 36% Y/Y, missing the consensus of $1.17.…

CAH

1 minute read

This Analyst Says Zentalis’ Increased Focus On WEE1 Program Is ‘Prudent’, Slashes Price Target By 37%

By Vandana Singh

August 10, 4:39 PM

Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL) decided to discontinue the development of oral SERD asset ZN-c5 and EGFR inhibitor ZN-e4 following the completion…

AZN

1 minute read

ReShape Lifesciences’ GIBI HD Calibration Tubes Scores FDA Approval For Tummy Tuck Procedures

By Vandana Singh

August 10, 2:35 PM

ReShape Lifesciences Inc (NASDAQ:RSLS) has received FDA 510(k) clearance for the disposable Gastro Intestinal Balloon Indicator (GIBI HD) calibration tube for…

RSLS

4 minute read

Biotech Daily: Cancer Causing Impurities In Merck’s Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon’s Monkeypox Trial

By Vandana Singh

August 10, 11:33 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADMP

1 minute read

GSK Confirms Rotavirus Vaccine Shortage, Hits Four African Countries: Report

By Vandana Singh

August 10, 11:18 AM

After disruptions at GSK plc (NYSE:GSK), supplies of rotavirus infection vaccine in children have either run out in Kenya, Tanzania,…

GSK

1 minute read

Organogenesis’ Q2 Operating Income Fell 50%, Lowers Annual Guidance

By Vandana Singh

August 10, 11:10 AM

Organogenesis Holdings Inc’s (NASDAQ:ORGO) Q2 FY22 sales reached $121.4 million, down 1% Y/Y, slightly ahead of the consensus of $120.90…

ORGO

1 minute read

Aridis’ Inhaled Pan-Coronavirus Antibody Cocktail Shows Encouraging Preclinical Action

By Vandana Singh

August 10, 10:40 AM

Aridis Pharmaceuticals Inc’s (NASDAQ:ARDS) inhaled treatment of its fully human monoclonal antibody cocktail AR-701 resulted in no detectable SARS-CoV-2 virus in…

ARDS

1 minute read

VYNE Therapeutics Shares Disappointing Data From Atopic Dermatitis Trial

By Vandana Singh

August 10, 10:34 AM

VYNE Therapeutics Inc (NASDAQ: VYNE) has announced results from the Phase 2a segment of Phase 1b/2a trial evaluating FMX114 for mild-to-moderate atopic dermatitis.

VYNE

1 minute read

To Avoid Supply Crunch, FDA Temporarily Allows Higher Impurity Levels In Merck’s Diabetes Drug: Report

By Vandana Singh

August 10, 7:43 AM

The FDA recently became aware of a nitrosamine impurity, Nitroso-STG-19 or NTTP, in certain samples of Merck & Co Inc's (NYSE: MRK) type 2 diabetes drug Januvia/Janumet (sitagliptin).

MRK